Dr. Andrea Feigl-Ding, PhD MPH, is the Founder and CEO of the Health Finance Institute, a former health economist at Harvard Chan School of Public Health, and was a former health economist with the Organisation for Economic Cooperation and Development (OECD). She also serves as Scientific Advisor to the Lancet Commission on Non-Communicable Diseases, Injuries, and Poverty. Dr. Feigl currently leads a SDG3 multisector initiative focused on innovative health financing for neglected global health issues.
Her work focuses on health systems financing and governance, universal healthcare, and cost-effectiveness of chronic disease interventions in developing countries. She led the largest worldwide longitudinal analysis of the political, social, and economic determinants of universal healthcare in 196 countries (published in Health Policy). She led the impact evaluation of a nationwide anti-smoking legislation in Chile (published in WHO Bulletin), and led the impact study of the award-winning intervention program for obesity/diabetes prevention in Amman, Jordan (project awarded Global Health Project of the Year from Consortium of Universities for Global Health).
She was notably the primary innovator of the Evidenced Formal Coverage Index for comparative health economics of achieving universal healthcare, and a primary author of the NCD Reframing Initiative, published in Lancet Global Health.
In addition to health systems analysis in Timor-Leste and Bangladesh, she conducted policy research at WHO-PAHO, evaluated projects in Ecuador, Paraguay, and Peru, and worked for the Canadian Institutes of Health Research. She has further authored several high level reports, including Development Aid Flows for Chronic Diseases for the Center for Global Development, a background paper on the political economy of universal healthcare for WHO, and a leading World Economic Forum/Harvard report on the global economic burden of chronic diseases, featured at the UN High Level Summit on NCDs in 2011.
She was a Salzburg Global Fellow, a Harvard Graduate Leadership Initiative Fellow, former President of the Harvard Club of Austria, and an internationally certified teacher in Cecchetti classical ballet from the Imperial Society for Teachers of Dance. A native of Austria, she received her PhD in global health and population from Harvard University, her MPH and BSc (First Class Honors with full scholarship) from Simon Fraser University in Canada, and her IB from Red Cross Nordic United World College in Norway.
(*Earned the legacy Sc.D. Doctor of Science degree, which was phased out by Harvard University beginning in 2016. The outdated Sc.D. in Global Health and Population is no longer conferred at Harvard, and has now been entirely replaced by the Ph.D. degree in the same field at Harvard. Thus, in everyday parlance, it has now become common practice that Harvard scientists holding grandfathered Sc.D. degrees often use 'Ph.D.' in lay/general audience settings).